Case Study

Case Study: MSABP Provides High Strength Pharmaceutical Wastewater Treatment Without Sludge Production

Source: Aquarius Technologies Inc.

The wastewater generated by the pharmaceutical processes employed by Teva Pharmaceutical Industries Ltd. contain COD levels approaching 50,000 mg/l. Treatment required the ability to adapt to a broad array of influent constituents, including high chloride levels and solvents. For this reason, Teva selected the MSABP™ process.

access the Case Study!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Water Online? Subscribe today.

Subscribe to Water Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Water Online

Please tell us more about you so that we can customize our newsletters to your specific interests: